Loading...
EUGIA US LLC — Dexamethasone Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #12 buyer for Dexamethasone · $2.7M import value · 58 shipments · UNITED STATES · DGFT Verified
EUGIA US LLC is the #12 importer of Dexamethasone from India with $2.7M in import value and 58 verified shipments. EUGIA US LLC holds a 1.3% market share in Dexamethasone imports based in UNITED STATES. The company sources from 1 verified supplier across 24 formulations shipped to 2 countries. Overall, EUGIA US LLC imports 27 pharmaceutical products worth $66.2M across 13 therapeutic categories.
Verified from 58 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $2.7M | 58 | 100.0% |
EUGIA US LLC sources Dexamethasone from 1 verified Indian supplier based on 58 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | RX CROSSROADS 3PL LLC | UNITED STATES | $3.2M | 64 | $50.0K |
| 12 | EUGIA US LLC ★ | UNITED STATES | $2.3M | 46 | $50.0K |
| 13 | MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $1.9M | 39 | $50.0K |
| 14 | MYLAN AUSTRALIA | AUSTRALIA | $1.9M | 53 | $35.4K |
EUGIA US LLC ranks #12 among 2,257 Dexamethasone importers from India. Average shipment value of $50.0K compared to the market average of $7.9K. The closest competitors by value are RX CROSSROADS 3PL LLC and MYLAN INSTITUTIONAL INC 2898.
Destination countries from 58 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.4M | 51 | 87.8% |
| UNITED STATES OF AMERICA | $329.0K | 7 | 12.2% |
EUGIA US LLC imports Dexamethasone to 2 countries. The primary destination is UNITED STATES receiving 87.8% of shipments worth $2.4M.
| Formulation | Value | Shipments |
|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION | $1.5M | 33 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTIONUSP 120MG/30ML (4MG/ML) (25 S PACK) (QTY: 1250 PACKS) | $88.3K | 3 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP 10 MG ML SDV 1ML SINGLE DOSE VIAL USA MARKET 25 S PACK QTY 3840 PACKS | $50.0K | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION 10MG ML 4010X25S | $50.0K | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION 10MG ML SDV 1 ML SINGLE DOSE VIAL 3792X25 S | $50.0K | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP 10 MG/ML-SDV (1 ML SINGLE DOSE VIAL)-USA MARKET(25 S PACK)(QTY: 3995 PACKS) | $50.0K | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTIONUSP 120MG/30ML (4MG/ML) (1219X25 S) | $50.0K | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTIONUSP 120MG/30ML (4MG/ML) (1238X25 S) |
What EUGIA US LLC and other importers must comply with to import Dexamethasone from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $17.9M worth of Dexamethasone through 8,777 shipments from 808 suppliers to 176 countries, serving 2,257 buyers globally. EUGIA US LLC imports $2.7M of this total, accounting for 1.3% of India's Dexamethasone exports with 58 shipments from UNITED STATES. This is verified from 58 customs shipment records covering 24 distinct formulations.
EUGIA US LLC's average Dexamethasone order value is $46.6K per consignment, based on 58 shipments totaling $2.7M. EUGIA US LLC is based in UNITED STATES and ranks #12 among all Dexamethasone importers from India by value. The company sources from 1 verified supplier in India.
EUGIA US LLC sources Dexamethasone from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($2.7M, 100.0%). This is based on 58 customs records.
EUGIA US LLC ranks #12 among 2,257 Dexamethasone importers from India with a 1.3% market share. The top 3 importers are RX CROSSROADS 3PL LLC ($3.2M), EUGIA US LLC ($2.3M), MYLAN INSTITUTIONAL INC 2898 ($1.9M). EUGIA US LLC processed 58 shipments from UNITED STATES.
EUGIA US LLC also imports these corticosteroids products. Each links to the detailed product page.
EUGIA US LLC imports 27 products worth $66.2M. Beyond Dexamethasone, top products include Ertapenem, Pantoprazole, Meropenem, Piperacillin, Sodium. View the complete EUGIA US LLC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Dexamethasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for EUGIA US LLC's Dexamethasone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EUGIA US LLC
Full Company Profile →
27 products · $66.2M total trade · 13 categories
| $50.0K |
| 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTIONUSP 120MG/30ML (4MG/ML) (1206X25 S) | $50.0K | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTIONUSP 120MG/30ML (4MG/ML) (850X25 S) | $50.0K | 1 |
EUGIA US LLC imports 24 distinct Dexamethasone formulations from India. The top formulation is DEXAMETHASONE SODIUM PHOSPHATE INJECTION with 33 shipments worth $1.5M.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,257+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for EUGIA US LLC.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dexamethasone. For current order-level data, contact TransData Nexus.